期刊文献+

99mTc-MIBI对尿毒症继发性甲旁亢的测定及意义 被引量:1

99mTc-MIBI Imaging of Secondary Hyperparathyroidism in Uremia and Its Significance
下载PDF
导出
摘要 目的了解 99mTc -甲氧基异丁基异晴 (MIBI)扫描对尿毒症伴继发性甲旁亢者甲状旁腺病灶的诊断价值及治疗的指导意义。 方法 16例尿毒症维持性血透患者根据血iPTH水平 ,分为正常组 3例、升高组 3例、显著升高组 10例。静脉注射 370~ 5 5 0mBq 99mTc -MIBI后 10~ 15min进行初始相采集 ,2~ 4h进行延迟相采集 ,观察甲状旁腺病灶 ,并与B超相比较。 结果正常组无 1例发现甲状旁腺病灶 ;升高组 1例发现甲状旁腺腺瘤 ;显著升高组有 5例发现甲状旁腺腺瘤 ,对 1,2 5 (OH) 2 D3 治疗反应差。而前 1例仅有iPTH明显升高 ,但同位素扫描无腺瘤 ,故治疗效果好。 结论 99mTc -MIBI双时相法对于甲状旁腺腺瘤的定位诊断优于B超 ,其检测阳性率与血iPTH的水平升高相一致 ,由此对指导 1,2 5 (OH) 2 D3 冲击治疗有一定意义。 Objective To evaluate 99mTc-MIBI in the localization of hyperfunctioning parathyroid tissues in uremia and guide therapy. Methods Sixteen patients underwent double phase 99mTc-MIBI imaging. According to serum iPTH levels, they were devided into 3 groups: normal iPTH?3 patients, high iPTH 3 patients, very high iPTH 10 patients. Results One adenoma was found in the high iPTH group and 5 adenomas were found in the very high iPTH group. The last group of patients with adenomas had poor reaction to 1,25(OH) 2D 3 treatment. Conclusion Double phase 99mTc-MIBI imaging is a promising technique for localization of parathyroid adenomas. Its high incidence is consistent with the high iPTH level. It is necessary for patients to undergo noninvasive imaging procedures before they receive 1,25(OH) 2D 3 treatment.
出处 《上海第二医科大学学报》 CSCD 2002年第2期140-142,共3页 Acta Universitatis Medicinalis Secondae Shanghai
关键词 尿毒症 99MTC-MIBI 甲状旁腺机能亢进 测定 诊断 uremia 99mTc-MIBI hyperparathyroidism
  • 相关文献

参考文献7

  • 1Coakley AJ,Kettle AG,Wells CP.99mTc -sestamibi a new agent for parathyroid imaging[].Nuclear Medicine Communications.1989
  • 2Taillefer R,Boucher Y,Potvin C,et al.Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with 99mTc -sestamibi (double - phase study)[].The Journal of Nuclear Medicine.1992
  • 3Lightowler C,Carroll MJ,Chesser AMS,et al.Idetification of autotransplanted parathyroid tissue by Tc - 99m methoxy isobutyl isonitrile scintigraphy[].Nephrology Dialysis Transplantation.1995
  • 4Zingraff J,Leger A,Skhiri H,et al.Localization of ectopic parathyroid tissue: usefulness of 99mTc-sestamibi scanning in a dialysis patient with severe secondary hyperparathyroidism[].Nephrology Dialysis Transplantation.1996
  • 5Caixas A,Berna L,Piera J,et al.Utility of 99mTc -sestamibi scintigraphy as a first-line imaging procedure in the preoperative evaluation of hyperparathyroidism[].Clinical Endocrinology.1995
  • 6Sofferman RA,Nathan MH,Fairbank JT,et al.Preoperative technetium 99mTc - sestamibi imaging[].Archives of Otolaryngology.1996
  • 7Fassbinder W,Brunner FP,Brynger Ⅱ,et al.Combined report on regular dialysis and transplantation in Europe XX[].Nephrology Dialysis Transplantation.1991

同被引文献9

  • 1Saliba W,El-Haddad B.Secondary hyperparathyroidism:pathophysiology and treatment[J].J Am Board Fam Med,2009,22:574-581.
  • 2Monge M,Shahapuni I,Oprisiu R,et al.Reappraisal of 2003 NKF-K/DOQI guidelines for management of hyperparathyroidism in chronic kidney disease patients[J].Nat Clin Pract Nephrol,2006,2:326-336.
  • 3London GM,Guerin AP,Marchais SJ,et al.Arterial media calcification in end-stage renal disease:impact on all-cause and cardiovascular mortality[J].Nephrol Dial Transpiant,2003,18:1731-1740.
  • 4Fretz JA,Zella LA,Kim S,et al.1,25-dihydroxyvitamin D3 induces expression of the Wnt signaling co-regulator LRP5 via regulatory elements located significantly downstream of the gene抯 transcriptional start site[J].J Steroid Biochem Mol Biol,2007,103:440-445.
  • 5Drueke T B.Cinacalcet treatment in dialysis patients with secondary hyperarathyroidism effects and open issues[J].Ther Apher Dial,2008,12:S2-S12.
  • 6Yueming Sun,Huihua Cai,Jianfeng Bai,et al.Endoscopic total parathyroidectomy and partial parathyroid tissue autotransplantation for patients with secondary hyperparathyroidism:a new surgical approach[J].Word J Surg,2009,33:1674-1679.
  • 7倪兆慧,周文彦.透析患者无力性骨病的新认识[J].中国血液净化,2009,8(10):523-525. 被引量:22
  • 8林善锬,钱家麒,汪关煜,吴兆龙,徐琴君,唐令诠,崔若兰,冯菡芳,梅长林.静脉注射和口服活性维生素D_3治疗尿毒症性甲状旁腺功能亢进的多中心临床研究[J].上海医学,1999,22(9):518-521. 被引量:3
  • 9孟建中.1,25(OH)_2D_3受体与肾性甲旁亢关系的研究进展[J].医学综述,2001,7(5):261-262. 被引量:8

引证文献1

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部